Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darifenacin vs PTENS for OAB in HTLV-1 Patients
NCT06616675Phase 4Completed
- Sponsor
- Hospital Universitário Professor Edgard Santos
- Start
- Mar 2022
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by Hospital Universitário Professor Edgard Santos. Primary endpoint: Overactive Bladder Symptom Score at 2 months. Started Mar 2022; status: completed.
Beyond the preview
Go deeper on NCT06616675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06616675.